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Aim: To study the in vitro and in vivo anticandidal activity of nanocapsulated bovine lactoferrin.Materials
& methods: In vitro and in vivo antimicrobial activities were conducted to study the anticandidal activities
of nanocapsules (NCs). Results: The NCs showed good anticandidal activities. The disruption of cell wall
and cell membrane was noted via microscopy studies. The NCs changed the normal growth profile of
Candida albicans. NCs reduced the colony forming unit in kidney and blood samples. Histopathological
examination showed better cell structure and coordination compared with untreated mice kidney. NCs
also enhanced the natural killing properties of C. albicans by epithelial cells. Conclusion:NCs have effective
anticandidal properties and have the potential as a therapeutic agent against candidiasis.
Lay abstract: Previous study revealed that lactoferrin had potent anticandidal action against C. albicans.
However, encapsulated lactoferrin has never been tested for anticandidal activity in detail. In the present
study, we evaluate nanocapsulated lactoferrin for anticandidal effects. To observe the anticandidal prop-
erties of encapsulated lactoferrin, various studies were conducted. Our findings showed that encapsulated
lactoferrin demonstrates remarkable efficacy against C. albicans.
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Pathogenic fungi such as Candida albicans are a key contributory agent for opportunistic infections. Immunocom-
promised individuals such as AIDS patients are at danger for opportunistic infections, which if not cured properly,
contribute to the death linked to their disorders. Inadequate availability of effective antifungal drugs and the in-
creasing prevalence of this life threatening fungal infection [1] have conspired to outgrow a necessity for developing
novel treatment options for opportunistic infections by pathogenic fungi such as C. albicans. Fungal cells which
categorized as eukaryotes shared numerous similarities with mammalian cells such as the nucleus contains DNA
organized into chromosomes with distinct cytoplasmic organelles and biosynthetic pathways similar to mammalian
cells. These likenesses have made extra problems in the design of antifungal agent with selective toxicity to fungal
cells [2,3]. Moreover, fungal cells, like various microorganisms, are surrounded by cell wall that consists of β-glucan,
chitin and mannoproteins, which offer physical support and defense to the cell and develop additional obstacle in
the design of antifungal agent [4]. The presence of complex biopolymer fungal cell wall, which provides the physical
protection of the yeast cell make the discovery of antifungal agents remains an important scientific challenge. The
insoluble polysaccharides in cell wall convey mechanical strength to the fungal cell [5]. Hence, the fungal cell wall
is emerging as an important better defined therapeutic target. For example, in C. albicans, it has been proposed
that β-glucan and chitin are related to the strength and shape of the cell wall, while mannoproteins are accountable
for the porosity, its antigenicity and adhesion [5]. As a result, no antifungal drug was available for the cure of
fungal infections until the finding of amphotericin B in 1953 [6]. This was followed by the development of many
new antifungal agents. However, with the advent of the immunocompromised diseases such as AIDS, the growing
number of patients alive with repressed immune systems and the deficiency of effective antifungal agent for the cure
of fungal infections, there has been renaissance in the awareness in the search for new, safer, and more efficacious
antifungal agents to battle serious fungal infections [7,8].
Concomitant with this, most of the consideration has been dedicated to the development of an ideal antifungal
agent. In so doing, an ideal antifungal agent should meet some criteria such as directed at a specific fungal target,
have multiple delivery methods, mainly oral availability with minimal toxicities or side effects. It is clear that
designing an antifungal drug that fulfills the above criteria is a key challenge and requires the identification of
new biological natural products such as lactoferrin. Lactoferrin is a multifunctional iron-binding glycoprotein
belonging to the transferrin family present in mammalian milk. It has also been shown to inhibit a wide range of
fungal, bacterial, viral and parasitic pathogens [9–12]. The anticandidal mode of action of lactoferrin was suggested
to be due to cell wall perturbation [9], as proved by cryo-scanning electron microscopy study which showed the
drastic changes in the cell wall, leading to the formation of surface blebs, swelling and cell collapse [13]. Similar
damages on cell wall were also reported by Nikawa et al. [14,15] after Candida exposure to both human and bovine
lactoferrin and it was concluded that the anticandidal activity of lactoferrin is due to direct contact of the protein
with the fungal cell surface [16]. However, encapsulated lactoferrin has never been tested for anticandidal activity in
detail. The successful administration of glycoprotein such as lactoferrin by oral route with maintaining their active
conformation remains a key task in the field of pharmaceutical technology. In the present study, we propose the use
of nanoencapsulated-based system for effective oral route-based delivery system of acid-labile lactoferrin. Thus in
the present study, the anticandidal activity of encapsulated lactoferrin was tested in in vivo in well-established mice
model and in vitro models.
For the past few decades, various formulations of nanoparticles have been used for drug delivery research to
increase therapeutic benefit [17]. For the current study, the in vitro and in vivo experiments were carried out by using
an encapsulated Fe-bovine lactoferrin (Fe-bLf; AEC-CP-Fe-bLf nanocapsules [NCs]) preparations in the treatment
of C. albicans. Alginate-enclosed chitosan–calcium phosphate-loaded Fe-bLf NCs were prepared by a combination
of nanoprecipitation and ionic gelation methods by Kanwar et al. [18] with modifications. Interestingly, in this study
for the first time, the efficacy of encapsulated Fe-bLf (NCs) as an antifungal agent was assessed, especially in the
case of C. albicans. Candidiasis is a fungal infection caused by 20 types of Candida species and most commonly
by the dimorphic fungus C. albicans. In contrast to other fungal pathogens, C. albicans is a member of the normal
flora in the digestive system, respiratory system, vaginal area and mouth. C. albicans do not produce any disease
in healthy individuals. The growth of C. albicans is suppressed by other normal flora in the body. However, if the
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normal flora is being disturbed,Candida can multiply rapidly and cause candidiasis. In recent years,Candida species
have also been identified as nosocomial pathogens [19]. Besides that, Candida can also be transmitted sexually. A
majority of candidal infections involves the skin or mucous membranes. This is because C. albicans is a strict aerobe
and therefore such surfaces are suitable for its growth. Previously, lactoferrin was reported to possess antifungal
properties by Kirkpatrick et al. [20]. Oral candidiasis is linked with impaired secretion of lactoferrin by the salivary
glands. For instance, in one study patients had a reduction as much as 65% in lactoferrin as compared with healthy
individuals. Moreover, nanoformulation of lactoferrin offers various advantages such as sustained release, better
efficiency, lesser side effects, target specificity and improved delivery [21]. Therefore, the current study was conducted
to evaluate the anticandidal activity of encapsulated lactoferrin (NCs).
Materials & methods
Preparation of endotoxin-free Fe-bLf
Endotoxin-free bLf was prepared from Australian bovine milk [22]. Endotoxin was evaluated by using Genscript
ToxinSensorTM, Chromogenic Limulus Amebocyte Lysate Endotoxin Assay Kit (Genscript ToxinSensor, NJ, USA).
Ferum-bLf was produced from bLf based on the previously described method established in Deakin’s laboratory
(VIC, Australia). Following treatment with mild acidic solution (pH 2.6), bLf was dialyzed for a duration of 48 h
in 0.1 M citric acid to remove bound metal ions and then saturated with ferric [Fe(III)] nonahydrate to form
bLf–Fe3+co-ordinate complexes to produce deep-red colored Fe-bLf. The Fe-bLf produced was loaded on to the
chitosan–calcium phosphate NCs and coated with alginate.
Preparation of alginate/EUDRAGIT R© S 100-enclosed chitosan–calcium phosphate-loaded Fe-bLf NCs
Alginate/EUDRAGITR© S (Rohm Pharmaceuticals, Darmstadt, Germany) 100-enclosed chitosan–calcium
phosphate-loaded Fe-bLf NCs were produced by a combination of nanoprecipitation and ionic gelation meth-
ods [18,23]. Calcium phosphate was prepared from its constituents by adding disodium hydrogen orthophosphate
(Na2HPO4) in a molar ratio of 4:1 to calcium chloride (CaCl2) in a dropwise manner while stirring continuously.
The suspension was sonicated at 4◦C to ensure a white precipitate of calcium phosphate was obtained. The calcium
phosphate (1% w/v) suspension produced was incubated for 24 h with 10% w/w Fe-bLf (from Section 3.2.1)
with constant stirring at 4◦C, at a pH ≤ 8.0, the isoelectric pH of lactoferrin, to adsorb Fe-bLf onto the NCs.
Following the electrostatic interaction of Fe-bLf on calcium phosphate (ceramic core), the suspension formed was
centrifuged and washed several times to eliminate traces of unbound protein and then freeze-dried. 0.01% w/w
chitosan solution in acetate buffer (pH 4) was added to calcium phosphate under constant stirring [18]. Then,
0.01% of cross linking agent, sodium tri-polyphosphate was added drop wise. Constant stirring at 6000 r.p.m.
(MSH-20D, Laboratory Instruments) for 12 h was performed to ensure that the nanoformulation attained the size
of 200 ± 40 nm, followed by freeze drying to ensure spherical shape of the samples is acquired. These nanocores
were then coated with alginate gel by using 2% w/v EUDRAGIT S 100/alginate solution and calcium chloride,
with 0.6% mass ratio of calcium alginate. Finally, the nanocarriers formed were washed and lyophilized. All these
experiments were conducted at 4◦C as to protect the polymeric and protein constituents in the formulation.
Candida albicans USM-K1
Yeast isolate used in this study was C. albicans USM-K1 obtained from the Microbiology Department of Universiti
Sains Malaysia Hospital, Kelantan (HUSM). These yeast strain was isolated from patient. The yeast strain was
stored in 50% glycerol stock at -80◦C to maintain their long-term viability. For all the experiments, the yeast
strains were subcultured for single colonies on Sabouraud dextrose agar (SDA) and incubated at 37◦C for 18 h in
an incubator (Loading Modell 100–800, Memmert, Schwabach, Germany).
C. albicans inoculum preparation
Inoculum size is very important and has to be standardized at a certain value to obtain reliable, reproducible and
significant results. Therefore, inoculum size was standardized throughout this study. A loop (25 μl) of yeast was
obtained from a pure single colony from SDA and was suspended in 10 ml of Sabouraud dextrose broth (SDB;
HiMedia, Mumbai, India). The broth was incubated overnight at 37◦C at 200 r.p.m. using an orbital shaker
(Model 420, Forma Orbital Shaker, Thermo Fisher Scientific, MA, USA). Then, the culture was standardized to
OD600 = 0.3 using spectrophotometer (Thermo Fisher Scientific) [24].
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Disk diffusion method
Antimicrobial activity was determined by modification of the disk diffusion method by [24]. Paper disk (Advantec
90 mm, Toyo Roshi Kaisha, Ltd, Tokoyo, Japan) with a diameter of 6 mmwas sterilized by autoclaving at 121◦C for
15 min and kept at room temperature until used. A 100 μl of mid exponential phase yeast cultures (OD600 = 0.3)
was spread onto SDA and left to dry for 1 h at room temperature. Then, the sterile disk was placed on the surface
of the plates. Sterile paper disks was impregnated with 20 μl NCs (2 mg/ml). Deionized water was used as a
negative control. Miconazole nitrate (30 μg/ml; Duchefa Biochemie, Haarlem, The Netherlands) was used as a
positive control. The plates were incubated in an incubator (Memmert) for 18 h at 37◦C. The test was conducted
in triplicate. Antimicrobial activity was determined by measuring the diameter of inhibition zone around the disk.
Minimal inhibitory concentration
MIC was determined based on the modification of the method of Ha˚versen et al. [25]. Microdilution method was
conducted using 96-well microtiter plate. A 96-well plate was filled with 130 μl of SDB in all the wells. 150
μl of deionized water was added in the first well of the first row and a twofold serial dilution was performed to
serve as a negative control. Subsequently, 150 μl of 10 μg/ml miconazole nitrate was added in the first well of
second row and a twofold serial dilution was conducted to serve as positive control. After that, 150 μl NCs were
added in the following row and a twofold serial dilution was performed. Then, 20 μl mid exponential phase yeast
cultures (OD600 = 0.3) were added in all the wells. The plates were incubated at 37◦C for 24 h in the incubator
(Memmert). The experiment was conducted in triplicate. The MIC was considered as the lowest concentration of
NCs whereby observable growth was inhibited. The results were confirmed by reading the absorbance of the plate
at the wavelength of 600 nm using an ELISA microplate reader (Multiskan Spectrum, Thermo Scientific, Vantaa,
Finland).
Time–kill study
Time–kill study was conducted according to the method of Sasidharan et al. [26] with slight modifications. In
order to evaluate the anticandidal effect of NCs with various MIC concentrations over time, growth profile
curves were plotted. NCs were prepared at a volume of 24 ml in 100 ml Erlenmeyer flask at concentrations of
0.5 MIC, MIC, 2 MIC and 4 MIC using SDB. 1 ml inoculum of yeast culture that has been standardized to
OD600 = 0.3 was inoculated into the flasks with various concentrations of NCs. The final concentrations of NCs
were maintained. 1 ml of inoculum was added into SDB without NCs as the control group. The experiment
was conducted in triplicate. The flasks were incubated at 37◦C at 200 r.p.m. using an orbital shaker (491 Forma
Incubated/Refrigerated Stackable Orbital Shaker, Thermo Scientific) for 48 h. The growth profile was studied for
48 h. Sampling was done every 4 h whereby 1 ml of culture was pipetted out aseptically from the Erlenmeyer flasks
starting from 0 h. Absorbance reading was taken using spectrophotometer (Biomate 3, Thermo Spectronic, NY,
USA) at the wavelength of 600 nm (OD600). SDB without NCs was used as the blank. After that, a graph was
plotted to determine the effect of NCs on the growth profile of C. albicans.
Morphological changes of C. albicans after treatment with NCs
A volume of 100 μl mid exponential phase yeast cultures at OD600 = 0.3 was spread onto SDA and incubated for
6 h at 37◦C. After that, a volume of 20 μl NCs (2 mg/ml) was dropped onto the agar surface. The plates were
swirled, spread with glass rod and incubated at 37◦C for 12, 24 and 36 h [27]. Normal cells that were vehicle treated
with deionized water only were used as the control. After the incubation of the plates at the stated duration, the
following tests were performed.
Observation of C. albicans morphological changes by scanning electron microscope
Scanning electron microscope (SEM) sample preparation was based on the Electron Microscopy Protocols of
Electron Microscopy Unit of School of Biological Sciences, Universiti Sains Malaysia. A planchette was prepared
with double-sided sticky tape. The sample positions were labelled carefully. A small piece of agar containing yeast
growth (about 5 mm × 5 mm) was cut and quickly placed on the double sided sticky tape. Cubes of agar were
taken out from the vehicle treated (control), 12, 24 and 36 h plates. The planchette was then placed in a filter
paper lined petri dish. The filter paper was wet with a few drops of 2% osmium tetroxide and the petri dish was
closed immediately. The petri dish was left in the fume hood for about 1–2 h. This process is known as ‘vapor
fixation’. Once the sample is fixed, the planchette is plunged into slushy nitrogen (-210◦C) and transferred to the
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‘peltier-cooled’ stage of the freeze dryer (Emitech K750, Emitech, Ashford, UK) and left to freeze dry for about
10 h. After that, the planchette containing the samples has to be kept in a desiccator if not viewed immediately.
The samples were sputtered with approximately 5–10 nm of gold before observation using scanning electron
microscope (Leo Supra 50 VP Field Emission SEM [FESEM], Carl-Ziess SMT, Oberkochen, Germany).
Observation of C. albicans morphological changes by transmission electron microscope
McDowell–Trump fixative was dropped onto the agar surface of the vehicle treated (control), 12, 24 and 36 h plates
to fix the yeast cells. The yeast cultures were scraped from the plates and placed into the microcentrifuge tubes. A
small amount of fixative was added into the microcentrifuge tubes. The eppendorf tubes were centrifuged (Sigma
1-141, Eppendorf, Sartorius, Germany) at 1000 ×g for 5 min. The supernatant was discarded and the pellet was
resuspended with the fixative. Subsequently, the sample was wrapped using a parafilm to avoid dehydration and
kept in the cold room at 4◦C until further use. Processing of the yeast samples for observation by a transmission
electron microscope (TEM) was conducted according to the ElectronMicroscopy Protocols of ElectronMicroscopy
Unit of School of Biological Sciences, Universiti Sains Malaysia. The sample was centrifuged at 1000–2000 ×g
for 15 min. The supernatant was discarded and the pellet resuspended with McDowell–Trump fixative prepared
in 0.1 M phosphate buffer (pH 7.2) for at least 2 h for fixation of the cells. The resuspended sample was then
centrifuged and the supernatant discarded. The pellet was resuspended in 0.1 M phosphate buffer (buffer wash 1).
The resuspended sample was centrifuged. The supernatant discarded and resuspended in 0.1 M phosphate buffer
(buffer wash 2). The resuspended sample centrifuged. The supernatant discarded and the pellet resuspended in 1%
osmium tetroxide prepared in phosphate buffer for 1 h (post-fixation). The resuspended sample was centrifuged.
The supernatant discarded and the pellet resuspended in distilled water (post-fix wash 1). The resuspended sample
was centrifuged. The supernatant discarded and the pellet resuspended in distilled water (post-fix wash 2). The
resuspended sample was centrifuged, the supernatant discarded and the tubes containing the pellet of fixed cells
were placed in a waterbath at 45◦C for about 15–20 min depending on the quantity of sample.
A 3% solution of agar was prepared by dissolving the agar in boiling distilled water. The solution was poured into
a test tube while it is still molten and placed in the water bath at 45◦C. The agar remains liquid at this temperature.
After the temperature of both the agar and the pellet has equilibrated to 45◦C, a small drop of agar was transferred
to the tube containing pellet of cells using a warm pipette. The pellet was stirred just sufficient to break the pellet
into small blocks and to be suspended in the agar. The agar with the suspended pellet was poured immediately to
a glass microscope slide. After that the agarose was placed in a refrigerator for approximately 1–2 min until the
agarose solidifies. Subsequently, the solidified agar contains the cells were cut into small cubes of about 1 mm3
with a sharp razor blade and then placed in a vial containing 50% ethanol. These cubes were then processed in
the same manner as pieces of a cohesive pellet or tissue. Dehydration was carried out at the following duration:
50% ethanol (15 min), 75% ethanol (15 min), 95% ethanol (15 min) twice, 100% ethanol (30 min) twice and
100% acetone (10 min) twice. The resin–acetone (1:1) mix was infiltrated into the samples in a rotator followed
by infiltration in Spurr’s mix overnight in the rotator. Subsequently, the samples were infiltrated in a new change
of Spurr’s mix for another 5 h in the rotator. Then, embedding was performed by insertion of samples in melted
resin before the samples were cured at 60◦C for 12–48 h. After processing, the samples were then sectioned using
an ultramicrotome. Ultra-thin sections were stained with uranyl acetate and lead citrate and observed under TEM
(Energy-filtered TEM Libra 120, Carl Zeiss).
Germ tube formation
Germ tube formationwas conducted according to themodification of themethod ofGhalehnoo et al. [28].C. albicans
were cultured on a SDA plate overnight at 37◦C in the incubator (Memmert). One colony was resuspended in 1
ml of fetal bovine serum and incubated in the waterbath at 37◦C for 1 to 2 h. Control contained fetal bovine serum
only without NCs. One drop was taken out using micropipette, placed on a microscopic slide and observed under
the phase contrast microscopy at 400× magnification (compound light microscope, Olympus BX41; Olympus
Optical Co. Ltd, Tokyo, Japan).
In vivo anticandidal activity
Laboratory animals
Swiss albino mice (male) weighing between 25 and 35 g were obtained from the Animal House, University Science
Malaysia (USM), Penang. The cages containing mice were placed in the Animal Room of Institute for Research of
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Table 1. Experimental groups and types of treatments for in vivo anticandidal activity study of
nanocapsules.
Experimental group Type of treatments
Group 1 (control) iv. C. albicans: 24 h gap, followed by treatment with PBS (intraperitoneal [ip.] once-daily for 3 days)
Group 2 (curative) iv. C. albicans: 24 h gap, followed by treatment with NCs, 2.5 g/kg body weight (ip. once-daily for 3 days)
NC: Nanocapsule; PBS: Phosphate-buffered saline.
Molecular Medicine (INFORMM), Universiti Sains Malaysia which is 24 h air-conditioned. Pellets and water were
given to mice ad libitum. The experimental protocols of this study were approved by the Animal Ethics Committee
USM (AECUSM) [USM/Animal Ethics Approval/2016/(723)]. Procedures of animal handling were carried out
in accordance to the internationally accepted principles for laboratory animal use and care. Animals were kept in
the cages for at least 1 week to allow acclimatization to the animal room conditions.
In vivo anticandidal assessment
A volume (0.1 ml) of 1 × 107 C. albicans cells/ml in phosphate-buffered saline (PBS) was injected intravenously
in the lateral tail vein of mice [29]. The mice were separated into two groups of six each and given treatment as
described in Table 1. All the mice were sacrificed by cervical dislocation on the fifth day after C. albicans was
inoculated intravenously.
A technique for plating organ homogenates which allows the quantitative determination of fungal populations
from the kidney of infected mice was conducted [30]. A volume of 0.1 ml of blood was withdrawn from the renal
artery with 0.1 ml of heparin (25 U/ml) as an anticoagulant added into the blood sample. Then the kidneys of each
mice were removed aseptically. The kidneys (1 g) were then placed into sterile centrifuge tubes and homogenized
using pestle andmortar in 5 ml of sterile PBS. Serial dilution of the homogenate and blood samples were conducted.
A total of 0.1 ml from each dilution was pipetted on the surface of three SDA agar plates and spread evenly. The
plates were incubated at 37◦C for 24 h. The experiment was conducted in triplicate. The colonies were then
enumerated and the colony forming unit (CFU) was calculated per gram of organ and per milliliter of blood
sample, respectively. The numbers of colonies from the control and the curative group were compared using t-test
by using SPSS 22.0 software for Windows. Values of p < 0.05 were considered significant.
Histopathological examination
After the mice were sacrificed, the kidneys were collected for histological examination [31]. Pieces of tissue not more
than 5 mm thick were cut from the kidneys. The tissues were then fixed in 10% buffered neutral formalin for
up to 24 h. Then, the tissues were dehydrated in three changes of 96% alcohol, for 2 h each change (ten-times
volume of tissue) and three changes of absolute alcohol, 2 h each change. The tissues were left overnight in xylene.
Subsequently, the tissues were transferred to fresh xylene until the tissues become transparent and clearing was
completed. Then, the tissues were placed in melted paraffin, three changes of 1 h each. After that, the tissues were
embedded in paraffin. The paraffin blocks were trimmed and placed on the object holder of the microtome (Leica
Camera AG, Wetzlar, Germany) for sectioning the blocks into 5–6 μm sections. The sections were then floated flat
on the floatation bath. Single sections were floated onto glass slides. Excess water was removed and sections were
dried in oven at 50–55◦C for at least 1.5 h. Sections were removed from oven and immersed in two changes of
xylene each of 5 min duration. Then, the sections were immersed in two changes (3 min each) of absolute alcohol,
two changes (3 min each) of 95% alcohol and then placed in tap water. The tissue sections were stained in Harris’
hematoxylin for 3–5 min. The sections were differentiated in acid alcohol and blue 5–10 min in tap water. Sections
were counterstained in 0.5% eosin and 70% alcohol for 2–3 min. After that, tissue sections were dehydrated in
two changes of 95% alcohol rapidly and left in two changes of absolute alcohol (3 min each). Sections were cleared
in two changes of xylene (3 min each) and mounted in Permount. A comparison of the microscopic features of the
kidneys of mice from Group 1 and Group 2 was conducted.
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Oral epithelial cell anticandidal activity
Isolation of oral epithelial cells
10 ml of unstimulated saliva was expectorated from a human subject into a sterile polypropylene tube (Labserv,
Warrington, UK) [32]. The sample was centrifuged (5804 R, Eppendorf ) at 800 ×g for 5 min. After washing with
sterile PBS, the cell pellet was resuspended in Hanks’ balanced salt solution (Corning, NY, USA) and passed over a
20 μm sterile nylon membrane. The epithelial cells retained on the nylon membrane were washed and resuspended
in cryopreservative (50% fetal calf serum, 25% Roswell Park Memorial Institute (RPMI) 1640 medium and 15%
dimethylsulfoxide) and stored at -70◦C until use.
Target cells
C. albicans USM-K1 was grown on SDA at 37◦C. One colony was used to inoculate 10 ml of SDB and incubated
for 18 h at 37◦C. The yeast cells were enumerated on a hemacytometer using trypan-blue exclusion. The method
was modified from Nomanbhoy et al. [33].
Vital staining of C. albicans in the coculture
C. albicans untreated with NCs (control), coculture of oral epithelial cells and C. albicans (1:2.6 ratio) and coculture
of oral epithelial cells and C. albicans (1:2.6 ratio) treated with NCs each in a volume of 2 ml/well were incubated
in a 24-well plate (Costar 3526, Corning). After 1-h incubation at room temperature, the cocultures were collected
and washed twice. Similarly, the untreated C. albicans were also collected and washed twice. Fluorescein diacetate
(50 μg/ml which stains living cells; Tokyo Chemical Industry Co. Ltd, Tokyo, Japan) and propidium iodide
(1 μg/ml which stains dead cells; Sigma–Aldrich, Saint-Quentin-Fallavier, France) were added simultaneously to
the cell pellets and left in the dark for 30 min at room temperature. Following the incubation, the cocultures
were washed with PBS by centrifugation at 800 ×g for 5 min, later by 20% fetal bovine serum and then washed
again with PBS. Finally, the pellets were resuspended in 100 μl of PBS and 5 μl of each coculture was placed on
a slide and observed under a dual-filter fluorescent microscope (Fluo BX53 Cell Sens, Olympus BX53, Olympus
Optical Co. Ltd). Blue light was selected as the suitable wavelength for viewing. Controls for vital staining included
the living and dead (heat-killed) C. albicans in the presence and absence of oral epithelial cells. The method was
modified from Nomanbhoy et al. [33].
Results
Determination of in vitro antimicrobial activity of NCs
The antimicrobial potential of NCs was assessed against C. albicans in terms of the zone of inhibition of yeast
growth. NCs show significant inhibition zone against C. albicans. The diameter of the inhibition zone measured
for C. albicans is 18.33 mm. The zone of clearance produced by the commercial antibiotic miconazole disk is larger
than that produced by the NCs disk (p < 0.05).
Minimal inhibitory concentration of NCs
The lowest concentration of NCs solution that can inhibit the growth of C. albicans is determined as MIC. NCs
show MIC value of 500 μg/ml against C. albicans in this study (Figure 1). The lowest concentration of peptide
that completely inhibits the growth of bacteria by visual inspection or growth percentage that was less than 5% of
negative control detection spectrophotometrically is defined as an MIC [34]. This is also applicable to yeast such as
C. albicans.
Fungicidal effect of NCs at various concentrations over time
Time–kill study was conducted to assess the fungicidal effect of NCs at 0.5 MIC (250 μg/ml), MIC (500 μg/ml),
2 MIC (1 mg/ml) and 4 MIC (2 mg/ml) over time. The result of the time–kill curves for C. albicans is shown in
Figure 2. The control without the treatment of NCs, showed a normal growth curve with various growth phases
such as a lag phase, a log phase and a stationary phase. However, at 1/2 × MIC, NCs demonstrated a large drop
in optical density (OD) reading after 8 h, which led to the stationary phase of the yeast growth. At MIC, 2 × MIC
and 4 × MIC, NCs produce absolute yeast eradication after only 4 h. The time–kill study showed the effectiveness
of NCs as an anticandidal agent against C. albicans over a duration of 48 h.
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Figure 2. Growth profile for Candida albicans in Sabouraud dextrose broth with 0 (control), 250 μg/ml ( 12 MIC),
500 μg/ml (MIC), 1000 μg/ml (2 MIC) and 2000 μg/ml (4 MIC) concentration of nanocapsules.
OD: Optical density.
Anticandidal mode of actions of NCs
Electron microscope studies were conducted to observe the effects of NCs on the extra and intramorphology of
C. albicans. The effects of NCs (2 mg/ml) on the extramorphological features of C. albicans were observed using
a SEM and a TEM. 4 × MIC (2 mg/ml) was chosen for electron microscopy studies to observe the anticandidal
mechanism of NCs on C. albicans and also to obtain clearer images. The SEM study shows that the NCs have the
ability to cause morphological and structural changes of C. albicans (Figure 3). Vehicle-treated yeast cells are treated
with deionized water only (control). The vehicle-treated yeast cells (control) were not altered by the NCs treatment
with normal cell morphology. The control cells were oval and demonstrated budding which was a characteristic of
the yeast cells (Figure 3A). Alteration of C. albicans morphology started to take place after 12 h of treatment of
NCs. The yeast cells started to get close to each other and were arranged in groups after 12 h of NC treatment. The
cells’ morphology was altered whereby the surface of cells showed indentations and signs of destruction (Figure 3B).
After 24 h of NC treatment, the extent of destruction of yeast cells was more significant. Indentations on the cell
surface were more prominent as the cells were severely damaged. The cells appeared more wrinkled. This is due
to cell wall perturbation and cell membrane disruption causing the collapse of cells (Figure 3C). After 36 h of
treatment with NCs, the yeast cells lost their original surface ultrastructure and the cells appeared uneven. The
yeast cells were completely destroyed. Very deep indentations were observed on the cell surface. Blebbing and cell
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Figure 3. Scanning electron microscopy micrograph of the untreated and nanocapsule-treated cells of Candida
albicans. (A) Control cells of C. albicans; (B) 12 h C. albicans cells treated with 2 mg/ml of NCs; (C) 24 h C. albicans cells
treated with 2 mg/ml of NCs and; (D) 36 h C. albicans cells treated with 2 mg/ml of NCs. ×5000 magnification used
for all images.
BD: Budding; BL: Blebbing; CO: Collapse; I: Indentation; NC: Nanocapsule; W: Wrinkle.
collapse was also observed (Figure 3D). At this stage, the yeast cells had lost their metabolic functions resulting in
cell death. This shows that NCs caused external morphological alterations to C. albicans and the degree of damage
increased proportionally with the increase in time of treatment with NCs. Based on the SEM observations, it was
evident that NCs have the ability to cause significant damages in the morphology of C. albicans.
From the SEM study, it can be observed that NCs caused severe surface ultrastructural damages. Further
intramorphological damages providing evidence of this SEM observation were obtained by TEM evaluation on
similarly treated C. albicans. Figure 4A shows the vehicle treated C. albicans (control) which are treated with
deionized water only. The control cells showed normal intramorphological structure with various organelles of
yeast cells such as nucleus, vacuole and lipid granule surrounded by the cytoplasm. The cytoplasm is surrounded
by the cell membrane and cell wall which has a uniformed thickness. However, Figure 4B shows that there were
changes in the intramorphological features of the yeast cells and lysis of the yeast cells that start to occur after
12 h of treatment with NCs. The internal organelles such as nucleus and vacuole were no longer seen. NCs have
altered the cytoplasm of C. albicans cells as compared with the untreated control cells. The internal organelles were
destroyed and dispersed which could have been due to the penetration of NCs into the yeast cells.
After 24 h of treatment of C. albicans with NCs (Figure 4C), severe alteration of the internal organelles was
observed. Impartiality of cell membrane from the cell wall and formation of pores were noticed which caused the
leakage of the intracellular contents. The leakage of intracellular contents resulted in some cytoplasmic contents
found extracellularly. Besides that, the disorganization of the cell wall and disruption of cell membrane were also
future science group www.futuremedicine.com
Research Article Leng, Vijayarathna, Jothy, Sasidharan & Kanwar
1 μm 1 μm
1 μm 1 μm
Figure 4. Transmission electron microscopy micrograph of a cross section of the untreated and nanocapsule-treated
cells of Candida albicans. (A) Control cells of C. albicans; (B) 12 h C. albicans cells treated with 2 mg/ml of NCs; (C) 24 h
C. albicans cells treated with 2 mg/ml of NCs and; (D) 36 h C. albicans cells treated with 2 mg/ml of NCs. ×6300
magnification used for all images.
CM: Cell membrane; CMD: Cell membrane disruption; CW: Cell wall; CWP: Cell wall perturbation; L: Leakage; LG: Lipid
granule; N: Nucleus; NC: Nanocapsule; PF: Pore formation; V: Vacuole.
observed. Moreover, the yeast cells which had been treated with NCs for 36 h showed cell wall perturbation, cell
membrane disruption and pore formation with a complete collapse of the cells (Figure 4D). The shrinkage of the
cytoplasm from the cell wall resulted in the halo of the cell. The leakage of the intracellular granulated contents
from the yeast cells due to pore formation on the cell wall was also discovered which eventually killed the cells. This
shows that the NCs have the ability to cause alterations in intramorphological features of the C. albicans cells. The
degree of changes deteriorated with the increase in time of treatment with NCs.
In vivo antimicrobial activity of NCs
Table 2 shows the mean of CFU/g of organs and CFU/ml of blood fromGroup 1 (control) and Group 2 (curative).
A significant reduction (p < 0.05) in yeast cells was found in the kidney and blood samples evaluated in Group
2 animals that received a 2.5 g/kg body weight dose of the NCs. The presence of C. albicans cells in in vivo
experiments was confirmed by using lactophenol cotton-blue staining method. A fivefold difference in CFU was
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Table 2. Effects of nanocapsules on Candida albicans recovered from the kid-
ney and blood of mice.
Group Kidney (CFU/g) Blood (CFU/ml of blood)
Group 1 (control) intravenous C. albicans and
intraperitoneal PBS
2.13 × 105 ± 13,412 2.69 × 105 ± 12,536
Group 2 (curative) intravenous C. albicans and
intraperitoneal NCs
4.12 × 104 ± 64* 4.99 × 104 ± 53*
All values are colony-forming units (CFU/g organ or CFU/ml of blood) expressed as a mean ± standard error of the
mean of three determinations.
*p  0.05 compared with the control (Student t-test).
CFU: Colony-forming unit; NC: Nanocapsule; PBS: Phosphate-buffered saline.
observed between the kidneys and blood samples of mice from the treated group compared with those of the control
group. The microscopic structures of the kidney depicted in Figure 5 show noticeable differences between Group
1 and Group 2. The microscopic examination reveals that the kidney from the Group 1 (Figure 5A) shows changes
in cell structure or unfavorable effects with a damaged glomerulus when observed under the light microscope
compared with NCs treated Group 2 (Figure 5B). The structure or coordination of cells in NCs treated kidney
from mice in Group 2 is better when compared with that of the mice in Group 1. The results show that NCs are
effective in inhibiting the Candida infection. Group 1’s mice which were infected with the C. albicans demonstrate
damage to the kidney glomerulus and changes in the cell structure. However, Group 2’s mice that were treated
with NCs do not reveal such damages to the kidney glomerulus and the cell structure is in a better shape probably
because NCs cause the inhibition of C. albicans as observed in the reduction of CFU in the kidney and blood of
Group 2.
Inhibition of germ tube formation by NCs
The inhibition of germ tube formation study’s result is depicted in Figure 6. Figure 6A shows the germ tube
formation by C. albicans after the incubation in fetal bovine serum for 1 h without the treatment of NCs (control).
After 1 h of incubation, germ tube formation was observed using a phase-contrast microscopy. However, there is
no germ tube formation seen after the treatment of the yeast cells with 2 mg/ml of NCs (Figure 6B). This finding
showed that NC treatment had effectively inhibited the germ tube formation in C. albicans.
Enhancement of the fungicidal properties of oral epithelial cells by NCs
The epithelial cell–C. albicans coculture growth inhibition assay was performed in the presence or absence of NCs
to confirm the enhanced inhibition of C. albicans by the cells and NCs. The vital staining of C. albicans in the
coculture is shown in Figure 7. Figure 7A demonstrates the verification of the right staining of live and dead C.
albicans cells in the presence of oral epithelial cells. Figure 7B shows the live (green) C. albicans cells following by
the 1-h incubation without human oral epithelial cells and stained with fluorescein diacetate (which stains living
cells green) and propidium iodide (which stains dead cells red). Figure 7C shows a fluorescent image of human oral
epithelial cells and C. albicans coculture following the 1-h incubation that reveals the presence of more live (green)
and less dead (red) C. albicans cells. This finding showed that the C. albicans cells were killed by epithelial cells only
to a certain extent. Figure 7D shows the fluorescence image of NC-treated coculture of human oral epithelial cell
and C. albicans following the 1-h incubation that reveals the predominantly dead C. albicans cells. The presence of
C. albicans cells on oral epithelial cells was confirmed by using lactophenol cotton-blue staining method. This result
confirmed that the NC treatment further enhances the killing of C. albicans by oral epithelial cell which caused
increased death in the C. albicans cells compared with epithelial cell–C. albicans coculture without the treatment
of NCs.
Discussion
Antimicrobial activity of NCs
The inhibitory effect of NCs on pathogenic yeasts C. albicans has been investigated in this study by using the
disk diffusion method. Presence of a clear zone indicated the susceptibility of the yeast against NCs. The observed
cleared antimicrobial zone might be produced by the spreading of the nanoparticles surrounding the disk in this
qualitative assay. Interestingly, negative control disk without NCs has exhibited no inhibition zone. Since NCs
showed antimicrobial properties against C. albicansUSM-K1 by the disk diffusion method, the minimal inhibitory
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Figure 5. Histomorphologies of the untreated and nanocapsule-treated kidney of mice infected with the Candida
albicans (H & E staining; Magnification: x100).
DG: Damaged glomerulus; G: Glomerulus; H & E: Hemotoxylin and eosin; RT: Renal tubule.
concentration was determined to identify the minimum concentration of NCs that could inhibit the yeast growth.
The lowest concentration of peptide that completely inhibited the growth of microorganisms by visual inspection
or growth percentage, that was less than 5% of negative control detection spectrophotometrically, was defined
as MIC [34]. The lowest concentration of antibiotic, causing absence of growth after 16–20 h of incubation, is
the MIC [19]. Both the effective chemotherapeutic agent and a suitable concentration to control an infection can
be evaluated. The lowest concentration should be maintained at the sites of infection considering that it is the
minimum concentration that can cure a particular disease [35]. The results of MIC can be correlated with known
drug concentrations targeted at different body parts. This method is important to determine the dose of drugs
for the treatment of diseases. MIC is the test commonly evaluated for most infections [36]. Typically, the bovine
lactoferrin at 100 μg/ml or more caused inhibition of C. albicans [37]. The MIC of NCs in this study which is
500 μg/ml is higher due to the coating of bLf by alginate. The MIC of NCs is higher as compared with peptides in
other research because NCs were produced from bLf which is a globular protein. For instance, a novel antimicrobial
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Figure 6. Effect of the nanocapsule treatment on germ
tube formation by Candida albicans
(Magnification: x400). (A) Untreated control C. albicans
and; (B) Nanocapsule-treated C. albicans.
GT: Germ tube.
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Figure 7. Fluorescent images of vital staining of
Candida albicans in the coculture of oral epithelial cells.
Whole unstimulated saliva was collected from healthy
human volunteer, and epithelial cell-enriched
populations were isolated and placed into the culture
with C albicans. (A) Live (green) and dead (red) C.
albicans with oral epithelial cells; (B) live C. albicans
without oral epithelial cells; (C) fluorescent image of the
phase-contrast image of untreated epithelial cells
cultured with C. albicans (predominantly live cells) and;
(D) fluorescent image of the phase-contrast image of
epithelial cells cultured with C. albicans (predominantly
dead cells) treated with 2 mg/ml nanocapsules. x400
magnification used for all images.
DCA: Dead Candida albicans; EC: Epithelial cell; LCA: Live
Candida albicans.
peptide derived from the modified N-terminal domain of bLf (L10) demonstrated MIC of 100 μg/ml against
C. albicans [38]. In another study, a N-terminal peptide of bovine lactoferrin known as lactoferricin-B (LF-B)
demonstrated MIC of only 10 to 40 μg/ml against C. albicans [39].
Fungicidal effect of NCs at various concentrations over time
Following the determination of minimal inhibitory concentration of NCs, time–kill study was conducted at various
concentrations to observe the prolonged anticandidal properties of NCs over a duration of time. The effect of
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NCs toward the growth profile of C. albicans was determined by OD or absorbance. This method is based on the
principle that microbial cells scatter light which striked them. Considering that C. albicans cells in a population
are approximately constant, the amount of light scattering is directly proportional to the biomass of cells which are
indirectly related to the number of cells. The degree of light scattering of C. albicans in this study was measured by
a spectrophotometer. Therefore, the population growth of C. albicans can be measured spectrophotometrically as
long as the population is high enough to enable detectable turbidity [19].
Time–kill studies are usually employed in the search of new antimicrobial agents. They are popular in preclinical
studies because they are relatively easy and cheap to be performed. Microbial regrowth after an initial reduction in
the initial inoculum is a significant problem. Time–kill study provides descriptive (qualitative) information on the
pharmacodynamics of antimicrobial agents. This technique provides valuable information about the cidal action
in relation to the concentration of the test substance over time [40].
In this study, time–killing profile was conducted to further confirm the results of in vitro antimicrobial activities.
The time–killing study revealed prolonged anticandidal activity when C. albicans was exposed to NCs at 0.5 MIC,
MIC and 2 MIC, 4 MIC for 48 h. In vitro antimicrobial methods are controversial because the findings do
not always correlate with the in vivo results or clinical outcome. Hence, this indicates that conventional MIC
determinations are insufficient for detecting the effectiveness of antimicrobial agents against pathogens. Time–kill
curves of C. albicans exposed to several NCs concentrations determine antimicrobial properties over a duration of
time and can also compare the differences in antimicrobial properties of NCs with different MIC concentrations.
The results of this study indicated that NCs possess good anticandidal properties whereby concentration de-
pendent killing was observed against the tested yeast strain. Interestingly, the potent anticandidal properties of
NCs in time–killing studies were demonstrated by NCs with MIC, 2 MIC and 4 MIC showing a decrease in the
viability OD600 = 2.2 in the evaluated strain. In any type of microbial infection, the first step in the investigation
of an appropriate therapeutic agent is the assessment of the causative microorganism’s predisposition in vitro to
potentially effective agents. Drugs that prove less effective in vitro are not likely to be considered for treatment.
The outcomes of this study also demonstrated that NCs is active against clinical isolates judging from its MIC
(500 μg/ml). Besides that, NCs at 2 MIC produced a viability decrease of OD600 = 2.2 against C. albicans. It is
possible that the NCs concentration of 2 MIC could be achieved at the site of C. albicans infection considering that
1 g or more doses of NCs can be administered orally. Therefore, these data suggest the requirement for evaluating
the in vitro and in vivo effectiveness of NCs against C. albicans. The findings of this study also clearly indicated the
potential of NCs to be developed as a therapeutic agent against C. albicans infection. Therefore, it can be concluded
that NCs have the ability to alter the growth profile of C. albicans at 0.5 MIC, MIC and 2 MIC compared with
the control group. The growth profile also proved that the MIC of NCs obtained in this study was fungicidal as C.
albicans was killed over the duration of 48 h. This phenomenon is important in drug development to ensure that
pathogens are totally inhibited and eliminated.
SEM & TEM observations
Subsequently, SEM and TEM were used to further study the in situ ultrastructural changes caused by NCs on
C. albicans cells at various exposure time and its preliminary anticandidal mode of action. The SEM method is
considerably beneficial compared with several other microscopic methods because it is 3D and almost the entire
cell is sharply focused. Other advantages include higher magnification, larger depth of focus, greater resolution and
easier sample preparation compared with TEM. However, a limitation of this method is that the sample must be in
solid form [41]. On the other hand, the disadvantage of TEM is that only one cell is shown as the single cell which
is considered as a representative for the particular treated group. The microscopic examinations of C. albicans using
SEM displayed that cells treated with NCs seemed irregular in morphology with cell wall modifications and clear
depression on the surface of cells. The TEM observations revealed irregular cell wall, ruptured cell membrane and
dense cytoplasm without distinguished features. Such modifications could be triggered by the interference of NCs.
The cell membranes of yeast form a barrier to the passage of small ions such as H+, K+, Na+ and Ca2+ and allow
cells and organelles to control the entry and exit of different substances. The permeability of cell membranes is vital
to many cellular functions such as maintenance of energy status of the cell, membrane coupled energy-transducing
process, solute transport, regulation of cell metabolism and control of turgor pressure [42,43]. Cell leakage from
both untreated and treated cells was almost similar in the first 12 h of incubation. This implies that NCs had
minimal effect on the cell membranes during the first 12 h. Within 24–36 h, a significant increase in leakage from
cells exposed to NCs could occur. In order for the cell leakage to occur, some alterations in the cell wall and cell
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membrane must occur. Interestingly, the exposure of C. albicans cells to NCs increased the permeability of cell
membrane because of the disruption of cell wall and cell membrane structures. That facilitated the cell leakage as
observed in the SEM and TEM studies. Therefore, the mechanism of NCs on C. albicans may be attributed to
the disruption of the cell wall and cell membrane which was seen by both SEM and TEM which showed severe
changes to the cell wall causing blebs on the surface and cell collapse. The mechanism of action of lactoferrin on
yeast such as C. albicans, Candida tropicalis and Candida krusei is cell wall disruption [39] and severe alterations to
the cell wall causing blebs on the surface, swelling and collapse of cells [44] are similar to the mechanism of NCs
in this study. Besides that, binding of lactoferrin to cell walls resulting in membrane disruption and leakage of
intracellular content [45] were also similar to the effect of NCs in this study. The observed mechanism of NCs on
the cell membrane in this study was comparable to the damaging effects of lactoferrin on the cell membranes of C.
albicans, Escherichia coli and Staphylococcus aureus as reported previously by using scanning electron microscopy [46].
The mechanism of action of antimicrobial peptides is different compared with conventional antifungal drugs.
It has been discovered in recent years that mitochondria plays an important role leading to cell death [47]. A recent
study by Andre´s et al. [47] proposed the plasma membrane Pma1p (P3A-type ATPase) as the lactoferrin molecular
target by using various yeast species. In accord with this findings, the treatment of hLf gradually increased the
cytoplasmic ATP levels in C. albicans. They also demonstrated that the specific inhibitor of mitochondrial F-type
ATPase proton pump (mtATPase) oligomycin is capable to nullify the antifungal activity of lactoferrin, signifying
the important task of mtATPase in the apoptotic yeast cells death. They recommended that the lactoferrin aimed
the plasma membrane Pma1p H ± ATPase, disturbing the cytoplasmic ion homeostasis (accumulation of H+
followed by effluxion of K+) and prompting a deadly mitochondrial malfunction. This early happening implicated
a usual mitochondrial ATP synthase activity facilitate the ATP increase and following hypothetical mitochondrial
proton flooding process. In brief, the authors concluded that the lactoferrin blocked the Pma1p H ± ATPase
and thus encouraged an apoptotic-like cell death process in yeast. Participation of mitochondrial H ± ATPase
(nonreturned) was important for the development of this apoptotic cell death in which the ionic homeostasis
agitation appears to lead traditional nonionic apoptotic events. Hence, in this study, the mechanism of NCs on
cell membrane causes pore formation and leakage of the intracellular components based on SEM and TEM studies
and caused progression to cell death, possibly with the involvement of mitochondria.
Inhibition of germ tube formation by NCs
The inhibition of germ tube formation was also carried out since the transformation of yeast to hyphae causes
colonization and invasion of host tissues. C. albicans is a dimorphic fungi that can change from the yeast form in
human to the mycelium form in the external environment in response to various environmental conditions such as
nutrients, carbon dioxide tension, oxidation–reduction potentials and temperature [19]. The transformation of C.
albicans cell morphology from yeast to hyphae is one of the most important characteristics that allows colonization,
invasion and survival of C. albicans in the host tissues during an infection. The mode of growth of C. albicans
is determined by environmental conditions. C. albicans can go through obvious changes in morphology due
to environmental conditions that involve various complex pathways such as MAPK and cAMP–PKA pathways.
Therefore, any interruption with the gene expression involved in MAPK pathway and cAMP–PKA pathway
can obstruct filamentation in C. albicans [48]. Attachment of microorganisms to surfaces and hypha formation
is dependent on various factors such as cell hydrophobicity, electrostatic forces and specific adhesins. The ALS
(agglutinin-like sequence) gene family which encodes cell surface glycoproteins is the most important among the
C. albicans adhesion molecules and hypha-specific genes. ALS1, ALS3 andHWP1 genes regulated by EFG1 control
C. albicans morphological changes [48]. Serum is an external factor that has an effect on hypha formation of C.
albicans [49,50]. Therefore, inhibition of C. albicans germ tube in this study by NCs could be due to the interference
of MAPK or cAMP–PKA pathway.
In oral candidiasis, the pathogenic importance of yeast as compared with the filamentous form is not clearly
understood. However, conditions that were found to be conducive for germ-tube formation increased attachment
of yeast cells to oral epithelial cells [51,52]. The presence of germ tubes increases the virulence of C. albicans in
vaginal candidiasis [52,53]. Hence, the inhibition of germ tube formation by NCs in this study decreases adherence
and virulence of C. albicans cells to oral epithelial cells and reduces the occurence of oral candidiasis.
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In vivo anticandidal activity of NCs
In vivo studies are important to prove the efficacy of in vitro findings obtained earlier in this study. Moreover, in
vivo animal model system has similar basic biology and physiology of both normal functions and malfunctions
as that in mice which yield important clues that could translate to human biology. In in vivo studies, the drug
consumed is subjected to the physiological conditions in the body of the organism being studied which could
be a limitation in the drug development process. NCs administered in mice in this study could be suppressed by
physiological conditions as NCs enter directly into the blood stream, then onto the infected site of the mice. Hence,
the current study was conducted to observe the effectiveness of NCs in the treatment of mice induced systemically
with candidiasis. Considering the fact that systemic candidiasis infection is caused by C. albicans, this study was
conducted on the systemic organs of mice. The advantage of studying animals instead of human beings is the
ability to monitor animals and the environment [54]. Animal models are effective to be employed for the study of
pathogenesis, host response and treatment of oral candidiasis infection [55]. Besides that, the utilization of animal
models also excludes the need to obtain tissue samples from the infected area in humans.
Although various species of animals such as rats, rabbits and monkeys have been utilized, mice have been
chosen in this study because mice are cheap, easily available and simple to handle [54]. An antimicrobial agent
given orally has to fulfill several criteria such as the ability to enter the bloodstream, distribution in the subcellular
areas, expression of antimicrobial properties at the site of infection and others in order to demonstrate optimum
antimicrobial properties. It has to be taken into consideration that mice do not usually get infected by C. albicans
compared with humans, and therefore, systemic infection needs to be induced experimentally [54]. In this study, the
systemic infection has been induced successfully and has been shown by a histopathological examination by H&E
staining. Blood and kidneys were chosen for the enumeration of the number of yeast cells becauseCandida infection
induced systemically is carried by the blood stream to the kidneys where filtration takes place. The findings of this
in vivo study showed that the NCs have the ability to reduce pathogenic C. albicans cells from both blood and
kidney of infected mice. Therefore, the in vivo study proves the efficacy of in vitro findings obtained in this study.
Besides that, the CFU results were parallel to the kidney histopathological examination. The findings of this study
clearly show that the NCs were very effective in the treatment of mice infected systemically by C. albicans based on
the CFU results and histopathological examination.
Enhancement of anticandidal properties of oral epithelial cells by NCs
Apart from the in vivo studies, vital staining method was conducted to observe the further enhancement of the
anticandidal properties of oral epithelial cells by NCs which will facilitate the strong anticandidal activity of oral
and vaginal epithelial cells to inhibit the growth of C. albicans. Epithelial cells from the oral mucosa act as a physical
barrier to prevent the entry of pathogens. Besides that, epithelial cells secrete various cytokines as a response to
microorganisms, express major histocompatibility complex class II antigens, process and presentation of foreign
antigens, and generate antibacterial and antifungal substances such as defensins, histatins and calprotectin. In other
words, epithelial cells play multiple roles in the mucosal immunity [56,57].
Recent studies have reported the ability of oral and vaginal epithelial cells to inhibit the growth of C. albicans in
vitro probably as an innate immune response. Oral epithelial cells have stronger anticandidal activity compared with
vaginal epithelial cells [33]. Similarly, oral epithelial cells in this study also caused inhibition of C. albicans. It has
been reported that cell contact by live epithelial cells with C. albicans is essential for vaginal and oral epithelial cell
anticandidal activity without depending on soluble factors [33]. Research on the specific portions of oral epithelial
cells showed that the carbohydrate moiety in epithelial cells has a role in the anticandidal properties but not the
surface proteins or lipids. This phenomenon was proven by the removal of anticandidal activity after the treatment
of epithelial cells with periodic acid. Studies have reported that proteins, glycoproteins or phospholipids were not
involved the anticandidal activity except for carbohydrate. Besides that, the anticandidal activity of vaginal epithelial
cells was also dependent on the carbohydrate moiety [33].
This study showed that antimicrobial peptides produced by epithelial cells were able to kill C. albicans only to
a certain extent since not many dead cells (red cells) were observed when the epithelial cells were incubated with
the yeast cells. However, more dead cells (red cells) were seen when NCs were added into the epithelial cells-yeast
coculture indicating that NCs further enhanced the anticandidal effect of epithelial cells. Hence, it was suggested
that NCs can contribute an important role against yeast infection as it has the ability to kill C. albicans. As such,
NCs can be incorporated in milk and other dairy products such as ice cream or yogurt as a functional food to
eliminate yeast infection through oral administration. Moreover, it was reported that the bovine lactoferrin derived
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antimicrobial peptides were suitable to be added to milk and other dairy products [58]. Interestingly, the inhibition
of germ tube formation properties of NCs also may decrease the virulence of C. albicans cells to oral epithelial cells.
Conclusion
In summary, the research presented in this article conclusively demonstrates the in vitro and in vivo anticandidal
potential of NCs. NCs are proven to be fungistatic, fungicidal and anticandidal agent for C. albicans. Furthermore,
NCs may have potential to treat candidiasis although this use will require additional detailed investigation.
Future perspective
Lactoferrin is a multifunctional iron-binding glycoprotein present in mammalian milk. Despite various research
reporting the anticandidal effects of lactoferrin, encapsulated lactoferrin has never been tested for anticandidal
activity in detail. Therefore, there is a need to evaluate encapsulated lactoferrin to understand in detail its anticandidal
activity. In view of this, alginate-enclosed chitosan–calcium phosphate-loaded Fe-bLf NCs were prepared and tested
for in vitro and in vivo anticandidal activity againstC. albicans. Collectively, all evidence from this study showed that
NCs have a potential for the development as a novel therapeutic agent for the treatment ofC. albicans infection. The
next steps for this research are to determine the appropriate curative concentration of NCs for human application
and to perform the clinical trials to treat yeast infection in human. Lastly, NCs also need to go through detailed
toxicity profiling for the better clarification of their appropriateness for the treatment of C. albicans infection in
human.
Summary points
Background
 The discovery of antifungal agents remains an important scientific challenge.
 Lactoferrin is a multifunctional iron-binding glycoprotein. It has been shown to inhibit a wide range of fungals
due to cell wall perturbation.
 Encapsulated lactoferrin has never been tested for anticandidal activity in detail.
Aim
 This research was conducted to investigate the in vitro and in vivo anticandidal activity of Alginate/EUDRAGIT R© S
100-enclosed chitosan–calcium phosphate-loaded Fe-bovine lactoferrin nanocapsules (NCs).
Results
 NCs showed a good antimicrobial activity against C. albicans with MIC value of 500 μg/ml.
 NCs disrupted the cell wall and cell membrane of C. albicans cells.
 The growth profile study confirmed the fungicidal effect of the NCs on C. albicans by changing the normal
growth profile.
 In vivo anticandidiasis study proved the efficacy of NCs in animal models.
 NCs enhanced the natural killing of C. albicans properties by epithelial cells.
Conclusion
 This is the first detailed work done on in vitro and in vivo anticandidal activities of NCs. NCs have effective
anticandidal properties and have the potential as a therapeutic agent against candidiasis.
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